About CatSci
CatSci is a company based in Cardiff (United Kingdom) founded in 2010. CatSci has raised $5.89 million across 2 funding rounds from investors including Keensight Capital and BOOST&Co. CatSci has completed 1 acquisition, including Reach Separations. CatSci operates in a competitive market with competitors including Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
- Headquarter Cardiff, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Catsci Ltd
- Date of Incorporation 10 Dec, 2010
- Jurisdiction CARDIFF
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$5.89 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Keensight Capital
& 1 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of CatSci
CatSci has successfully raised a total of $5.89M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in CatSci
CatSci has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Keensight Capital and BOOST&Co.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Keensight Capital is recognized as a European Growth Buyout investor.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for CatSci
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CatSci
CatSci has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Reach Separations.
Investment portfolio details for CatSci
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Small molecule analysis and purification services are provided using chromatography.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for CatSci
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - CatSci
Detailed financials for CatSci
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Catsci Comparisons
Peer comparison for CatSci
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CatSci
CatSci operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Evotec, Crown Bioscience, Alloy Therapeutics, Domainex and NIH, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drug discovery and development services are provided to biopharma sector.
|
|
| Locked | Locked | Locked |
Cancer and CVMD drugs are developed using PDX models.
|
|
| Locked | Locked | Locked |
Drug discovery services are provided for therapeutic development.
|
|
| Locked | Locked | Locked |
Drug discovery CRO company for epigenetic research and inflammatory diseases
|
|
| Locked | Locked | Locked |
Drug discovery services are provided to the biopharma sector.
|
|
| Locked | Locked | Locked |
Drug discovery and development research services are provided.
|
Detailed competitors of CatSci
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Catsci
Complete news archive for CatSci
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CatSci
CatSci was founded in 2010 and raised its 1st funding round 12 years after it was founded.
CatSci is headquartered in Cardiff, United Kingdom. It is registered at Cardiff, Wales, United Kingdom.
CatSci is a funded company, having raised a total of $5.89M across 2 funding rounds to date.
CatSci was founded in 2010 and is headquartered in Cardiff, United Kingdom. Drug discovery services are delivered by the company within the pharmaceutical sector. Operations focus on supporting research and development processes for clients seeking to advance therapeutic candidates. Expertise in synthesis, analytics, and formulation is applied across projects, with a base in the UK facilitating international collaborations in the life sciences industry.
CatSci's top competitors include Evotec, Crown Bioscience and NIH.
CatSci has made 1 acquisition, including Reach Separations.
CatSci has 2 investors. Key investors include Keensight Capital, and BOOST&Co.